Syndax Pharmaceuticals (SNDX) P/E (2016 - 2026)
Syndax Pharmaceuticals (SNDX) P/E from Mar 31, 2016 to Jul 21, 2026. The TTM Syndax Pharmaceuticals (SNDX) P/E is -8.10. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Syndax Pharmaceuticals (SNDX)
| Year | P/E | Change |
|---|---|---|
| 2026 | -8.10 | +27.21% |
| 2025 | -6.37 | +79.98% |
| 2024 | -3.54 | -66.54% |
| 2023 | -10.58 | -93.99% |
| 2022 | -176.01 | -280.98% |
| 2021 | 97.25 | -764.59% |
| 2020 | -14.63 | +175.54% |
| 2019 | -5.31 | +193.59% |
| 2018 | -1.81 | -57.14% |
| 2017 | -4.22 | -11.69% |
| 2016 | -4.78 | N/A |
Comparison Syndax Pharmaceuticals (SNDX) P/E with competitors
Syndax Pharmaceuticals (SNDX) P/E is -8.10.